Changed Risks for ENDO INTERNATIONAL PLC (ENDP)

Here are risks that changed year over year. risks from the recent filings of ENDO INTERNATIONAL PLC. Our algorithms work hard to highlight risks unique to this company.

New tariffs and evolving trade policy between the United States and other countries, including China, may have an adverse effect on our business and results of operations

We have a substantial amount of indebtedness which could adversely affect our financial position and prevent us from fulfilling our obligations under such indebtedness, which may require us to refinance all or part of our then outstanding indebtedness Any refinancing of this substantial indebtedness could be at significantly higher interest rates Additionally, we have a significant amount of floating rate indebtedness and an increase in interest rates would increase the cost of servicing our indebtedness Despite our current level of indebtedness, we may still be able to incur substantially more indebtedness This could increase the risks associated with our substantial indebtedness

Public concern around the abuse of opioids, including law enforcement concerns over diversion and marketing of opioids, and regulatory efforts to combat abuse, could result in costs to our business

Our business and financial condition may be adversely affected by legislation

We could be adversely affected by the risks related to our Astora business, which previously manufactured medical devices

Changes in the method of determining the London Interbank Offered Rate (LIBOR), or the replacement of LIBOR with an alternative reference rate, may materially adversely affect our interest expense related to our outstanding debt

Texas v Azar

We have no plans to pay regular dividends on our ordinary shares or to conduct ordinary share repurchases

2018

We have been, continue to be and may be the subject of lawsuits, product liability claims, other significant legal proceedings, government investigations or product recalls for which we may be unable to obtain or maintain insurance adequate to cover potential liabilities

Our ability to fund our operations, maintain liquidity and meet our financing obligations is reliant on our operations, which are subject to significant risks and uncertainties

Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees

Decreases in the degree to which individuals are covered by healthcare insurance could result in decreased use of our products

We are incorporated in Ireland, and Irish law differs from the laws in effect in the US and may afford less protection to, or otherwise adversely affect, our shareholders